Your browser doesn't support javascript.
loading
Cost-effectiveness of adjuvant chemotherapy for high-risk stage II and stage III colon cancer in South Africa.
Tan, Sarah Xinhui; Pumpalova, Yoanna; Rogers, Alexandra M; Bhatt, Kishan; Herbst, Candice-Lee; Ruff, Paul; Neugut, Alfred I; Hur, Chin.
Afiliação
  • Tan SX; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Pumpalova Y; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Rogers AM; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Bhatt K; Department of Medicine, Vagelos College of Physicians and Surgeons, Columbia University, New York, New York, USA.
  • Herbst CL; Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Ruff P; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, South Africa.
  • Neugut AI; SAMRC/Wits Developmental Pathways to Health Research Unit, Department of Paediatrics, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
  • Hur C; Division of Medical Oncology, Department of Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Cancer Med ; 12(14): 15515-15529, 2023 07.
Article em En | MEDLINE | ID: mdl-37318753

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias do Colo Idioma: En Ano de publicação: 2023 Tipo de documento: Article